Project Details
| Short title | BG-T187-101 |
|---|---|
| Status | Finished |
| Effective start/end date | 11/11/24 → 6/08/26 |
CTU: A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of BG-T187, an EGFR×METTrispecific Antibody, Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors.
- Parsonson, Andrew (Primary Chief Investigator)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- McHugh, Tracey (Clinical Trial Unit Staff)
Project: Research